NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
OPRA
Opera Limited
OPRA's fundamentals are strong: revenue grew 23% and it turned 18% of its revenue into free cash flow. Its PE of 11x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect OPRA's strong growth to continue.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
OPRA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
OPRA's revenue, profitability, cash flow and balance sheet are all currently healthy.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
OPRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $10.24 | -35% |
| Current | 11x | $15.63 | — |
| Fair | 16x | $22.42 | +43% |
| Expensive | 28x | $38.34 | +145% |
Historical ranges are pointers, not guarantees.
OPRA has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
OPRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
OPRA has the edge over NBIS on the outlook, with more favorable earnings expectations.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
OPRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.38 | +55% |
| Q1 2026 | $1.25 | +33% |
| Q4 2025 | $1.18 | +30% |
| Q4 2025 | $0.89 | -55% |
| Q2 2025 | $0.89 | -54% |
| Q1 2025 | $0.94 | -50% |
| Q4 2024 | $0.91 | -52% |
| Q3 2024 | $1.97 | +170% |
OPRA has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
OPRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $177.5M | +24% |
| Q1 2026 | $175.8M | +23% |
| Q4 2025 | $177M | +21% |
| Q4 2025 | $151.9M | +23% |
| Q2 2025 | $143M | +30% |
| Q1 2025 | $142.7M | +40% |
| Q4 2024 | $145.8M | +29% |
| Q3 2024 | $123.2M | +20% |
OPRA has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +3.7 points |
| Q1 2026 | 17% | +2.5 points |
| Q4 2025 | 17% | -2.3 points |
| Q4 2025 | 15% | -4.1 points |
| Q2 2025 | 13% | -7.3 points |
| Q1 2025 | 15% | -4.4 points |
| Q4 2024 | 19% | +0.9 points |
| Q3 2024 | 19% | +3.2 points |
OPRA's operating margin was 16% last quarter, up 3.7 points from the same quarter a year ago.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
OPRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.8M | -28% |
| Q1 2026 | $36.8M | +140% |
| Q4 2025 | $39.6M | +101% |
| Q4 2025 | $22.5M | -27% |
| Q2 2025 | $30.3M | +109% |
| Q1 2025 | $15.3M | +42% |
| Q4 2024 | $19.7M | -20% |
| Q3 2024 | $30.8M | +93% |
OPRA generated $121M in free cash flow over the past year, up 26% from the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over OPRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
OPRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -67K shares |
| 1 year | +0.8% | +760K shares |
| 3 years | -0.3% | -237K shares |
| 5 years | -21% | -24.7M shares |
| Available history | -19% | -21.9M shares |
OPRA has 91M diluted shares, up 0.8% from a year ago, despite $27M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $12.8M |
| Q4 2025 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OPRA spent $27M buying back its own shares over the past year, after none the year before.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
OPRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
| Q3 2024 | -1.0x | Net Cash |
OPRA has more cash than debt.
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
OPRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 9.3 | Oversold |
OPRA's weekly RSI is 40 (neutral) and its Stochastic is 9 (oversold).
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
OPRA PE vs Communication Services Sector
| Metric | OPRA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 16x | 31% below |
| PE % | 25 | 26 | 1 pt below |
OPRA has the edge over NBIS on valuation relative to its sector.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has stronger trend alignment. NBIS is above 1 of 4 weekly averages versus OPRA above 1 of 5.
OPRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.7 | 6.6% below |
| 20 week MA | $18.2 | 14% below |
| 50 week MA | $16.6 | 5.6% below |
| 100 week MA | $16.9 | 7.6% below |
| 200 week MA | $15.3 | 2.4% above |
OPRA has fallen below most of its moving averages, though it's still 2.4% above its 200-week average.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over OPRA on returns for 2026, with the stronger performance.
OPRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.44 | $8.49 | -10% |
| 2021 | $8.49 | $7.19 | -15% |
| 2022 | $7.19 | $5.98 | -17% |
| 2023 | $5.98 | $13.2 | +121% |
| 2024 | $13.2 | $19.0 | +43% |
| 2025 | $19.0 | $14.5 | -24% |
| 2026 YTD | $14.5 | $15.6 | +7.7% |
OPRA has finished lower in four of the last six years. It's up 7.7% so far in 2026.